These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32311305)

  • 1. Include Payers in Your Product Development and Clinical Use Processes.
    Schaum KD
    Adv Wound Care (New Rochelle); 2020 Nov; 9(11):632-635. PubMed ID: 32311305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of new technology into clinical practice after FDA approval.
    Govil A; Hao SC
    J Interv Card Electrophysiol; 2016 Oct; 47(1):19-27. PubMed ID: 27565971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare payment for new technologies. Can the process be improved despite conflicting goals? An ECRI technology management assessment.
    J Health Care Technol; 1986; 3(1):13-32. PubMed ID: 10300959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval.
    Neumann PJ; Crummer E; Chambers JD; Tunis SR
    Milbank Q; 2023 Dec; 101(4):1047-1075. PubMed ID: 37644739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
    Chambers JD; May KE; Neumann PJ
    Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmology.
    Hwang TJ; Ciolino JB
    JAMA Ophthalmol; 2015 Apr; 133(4):373-4. PubMed ID: 25675029
    [No Abstract]   [Full Text] [Related]  

  • 8. The blind hog and the acorn: Medicare coverage for investigational devices.
    Betz R
    J Healthc Resour Manag; 1995 Mar; 13(3):31-2. PubMed ID: 10154864
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician-initiated payment reform: a new path toward value.
    Gondi S; Ferris TG; Patel KK; Song Z
    Am J Manag Care; 2019 Sep; 25(9):431-437. PubMed ID: 31518092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New obstacles in the path of marketing new medical devices.
    Bucci VA; Reiss JB; Hall NC
    J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimbursement of dressings: a WUWHS statement.
    Téot L; Cherry G; Denis C; Dervaux B; Duncan G; Gottrup F; Harding K; Kerihuel JC; Lautenberg A; Mani R; Meaume S; Messina R; Morris S; Orsted H; Pavlovic M; Peter R; Ricci E; Sibbald G; Sussmann G; Trueman P;
    Int Wound J; 2006 Dec; 3(4):296-301. PubMed ID: 17199765
    [No Abstract]   [Full Text] [Related]  

  • 12. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing efficiency: step by step.
    McGivney WT
    Physician Exec; 1991; 17(4):35-7. PubMed ID: 10112658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational: what's in a name.
    McGivney WT
    Physician Exec; 1991; 17(2):30-1. PubMed ID: 10113675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical device payment controversy rages on.
    Brown E
    Physician Exec; 1995 Nov; 21(11):40-1. PubMed ID: 10153735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare challenges and solutions--reimbursement issues in treating the patient with colorectal cancer.
    Kaa K
    J Manag Care Pharm; 2007 Aug; 13(6 Suppl C):S19-26. PubMed ID: 17713991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program.
    Moneer O; Rathi VK; Johnston JL; Ross JS; Dhruva SS
    JAMA Cardiol; 2023 Dec; 8(12):1174-1181. PubMed ID: 37878306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant center regulations--a mixed blessing? An ASTS Council viewpoint.
    Abecassis MM; Burke R; Cosimi AB; Matas AJ; Merion RM; Millman D; Roberts JP; Klintmalm GB;
    Am J Transplant; 2008 Dec; 8(12):2496-502. PubMed ID: 19032221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and Medicaid programs; statement of policy concerning approval of statewide hospital reimbursement systems demonstration projects--Health Care Financing Administration. Statement of policy.
    Fed Regist; 1982 Oct; 47(196):44612-4. PubMed ID: 10298792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Centers for Medicare and Medicaid Service's lack of reimbursement for postoperative urinary tract infections in elderly emergency surgery patients justified?
    Zielinski MD; Thomsen KM; Polites SF; Khasawneh MA; Jenkins DH; Habermann EB
    Surgery; 2014 Oct; 156(4):1009-15. PubMed ID: 25239361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.